Weiyang He
- Molecular Biology top 10%
- Cancer Research top 5%
- Surgery
- Pulmonary and Respiratory Medicine
- Immunology
- Topics
- MicroRNA in disease regulation (7 papers)Extracellular vesicles in disease (7 papers)Bladder and Urothelial Cancer Treatments (7 papers)
- Journals
- SHILAP Revista de lepidopterologíaThe FASEB JournalInternational Journal of Molecular Sciences
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Weiyang He
39 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 715
- Cancer Research 343
- Surgery 181
- Pulmonary and Respiratory Medicine 154
- Immunology 92
Countries citing papers authored by Weiyang He
This map shows the geographic impact of Weiyang He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyang He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyang He more than expected).
Fields of papers citing papers by Weiyang He
This network shows the impact of papers produced by Weiyang He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyang He. The network helps show where Weiyang He may publish in the future.
Co-authorship network of co-authors of Weiyang He
This figure shows the co-authorship network connecting the top 25 collaborators of Weiyang He. A scholar is included among the top collaborators of Weiyang He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiyang He. Weiyang He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 2 | |
| 3 | 33 | |
| 4 | 4 | |
| 5 | 21 | |
| 6 | 17 | |
| 7 | 45 | |
| 8 | 2 | |
| 9 | 13 | |
| 10 | 6 | |
| 11 | 126 | |
| 12 | 107 | |
| 13 | 70 | |
| 14 | 17 | |
| 15 | 23 | |
| 16 | 11 | |
| 17 | 43 | |
| 18 | 1 | |
| 19 | 4 | |
| 20 | [A new method for study of the effect of drugs on cancer cells--31PNMR with perfused cell system]. | 1 |
About Weiyang He
Weiyang He is a scholar working on Cancer Research, Hepatology and Toxicology, having authored 40 papers that have together received 1.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Extracellular vesicles in disease (7 papers) and Bladder and Urothelial Cancer Treatments (7 papers). The work is most often cited by research in Cancer Research (343 citations), Molecular Biology (715 citations) and Nephrology (70 citations). Weiyang He has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xin Gou, Hubin Yin, Gongmin Zhu, Lin Fan, Xinyuan Li, Qifa Ye, Yanfeng Wang, Nian Liu, Lijiao Pei and Xin Gou. Their work appears in journals such as SHILAP Revista de lepidopterología, The FASEB Journal and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.